Apadamtase alfa with cinaxadamtase alfa (recombinant adamts13) – July 2026

  • Brand names:
    • Adzynma®
  • Pharmaceutical Company:
    • TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.
  • Condition/Indication: Congenital thrombotic thrombocytopenic purpura (cTTP)
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026